Literature DB >> 7503561

High-level expression and purification of coffee bean alpha-galactosidase produced in the yeast Pichia pastoris.

A Zhu1, C Monahan, Z Zhang, R Hurst, L Leng, J Goldstein.   

Abstract

alpha-Galactosidase isolated from coffee beans cleaves the terminal alpha-galactose residues from oligosaccharide chains on blood group B red cells, thus generating group O cells. Such enzymatically converted red cells not only maintain full erythrocyte integrity and viability in vitro, but also demonstrate immune tolerance and a normal life span in vivo. In order to produce large quantities of recombinant alpha-galactosidase for use in the study of blood-type conversion, we subcloned the cDNA coding for coffee bean alpha-galactosidase into the EcoRI site of the vector pPIC9 in order to express the enzyme in Pichia pastoris, a methylotrophic yeast strain. After P. pastoris transformation, colonies were screened for high-level expression of alpha-galactosidase, based on enzyme activity. In order to increase enzyme production, the growth conditions in the shake flask culture and fermentor culture were optimized. Under the conditions applied, biologically active alpha-galactosidase was produced and secreted into the culture medium at a level of approximately 0.4 g per liter of the fermentor culture. The protein was purified to apparent homogeneity by a simple chromatography procedure, as suggested by a single band of 41 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Its homogeneity was further confirmed by chromatofocusing and N-terminal sequencing. P. pastoris appears to be the choice as host for the large-scale production of recombinant alpha-galactosidase used for blood type conversion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7503561     DOI: 10.1006/abbi.1995.9928

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Cloning and high-level expression of alpha-galactosidase cDNA from Penicillium purpurogenum.

Authors:  H Shibuya; H Nagasaki; S Kaneko; S Yoshida; G G Park; I Kusakabe; H Kobayashi
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

2.  Identification of a GH110 subfamily of alpha 1,3-galactosidases: novel enzymes for removal of the alpha 3Gal xenotransplantation antigen.

Authors:  Qiyong P Liu; Huaiping Yuan; Eric P Bennett; Steven B Levery; Edward Nudelman; Jean Spence; Greg Pietz; Kristen Saunders; Thayer White; Martin L Olsson; Bernard Henrissat; Gerlind Sulzenbacher; Henrik Clausen
Journal:  J Biol Chem       Date:  2008-01-28       Impact factor: 5.157

Review 3.  Production of Industrial Enzymes via Pichia pastoris as a Cell Factory in Bioreactor: Current Status and Future Aspects.

Authors:  Zeynep Efsun Duman-Özdamar; Barış Binay
Journal:  Protein J       Date:  2021-02-15       Impact factor: 2.371

Review 4.  Recombinant protein expression in Pichia pastoris.

Authors:  J M Cregg; J L Cereghino; J Shi; D R Higgins
Journal:  Mol Biotechnol       Date:  2000-09       Impact factor: 2.860

5.  Induced Remodeling of Porcine Tendons to Human Anterior Cruciate Ligaments by α-GAL Epitope Removal and Partial Cross-Linking.

Authors:  Kevin R Stone; Ann Walgenbach; Uri Galili
Journal:  Tissue Eng Part B Rev       Date:  2017-02-14       Impact factor: 6.389

Review 6.  In Situ "Humanization" of Porcine Bioprostheses: Demonstration of Tendon Bioprostheses Conversion into Human ACL and Possible Implications for Heart Valve Bioprostheses.

Authors:  Uri Galili; Kevin R Stone
Journal:  Bioengineering (Basel)       Date:  2021-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.